Literature DB >> 12163268

Eight-plasmid system for rapid generation of influenza virus vaccines.

Erich Hoffmann1, Scott Krauss, Daniel Perez, Richard Webby, Robert G Webster.   

Abstract

The antigenic variation of influenza A virus hemagglutinin (HA) and neuraminidase (NA) glycoproteins requires frequent changes in vaccine formulation. The classical method of creating influenza virus seed strains for vaccine production is to generate 6 + 2 reassortants that contain six genes from a high-yield virus, such as A/PR/8/34 (H1N1) and the HA and NA genes of the circulating strains. The techniques currently used are time-consuming because of the selection process required to isolate the reassortant virus. We generated the high-yield virus A/PR/8/34 (H1N1) entirely from eight plasmids. Its growth phenotype in embryonated chicken eggs was equivalent to that of the wild-type virus. By using this DNA-based cotransfection technique, we generated 6 + 2 reassortants that had the antigenic determinants of the influenza virus strains A/New Caledonia/20/99 (H1N1), A/Panama/2007/99 (H3N2), A/teal/HK/W312 (H6N1), and A/quail/HK/G1/97 (H9N2). Our findings demonstrate that the eight-plasmid system allows the rapid and reproducible generation of reassortant influenza A viruses for use in the manufacture of vaccines. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163268     DOI: 10.1016/s0264-410x(02)00268-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  185 in total

1.  Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82.

Authors:  Irina V Alymova; Amanda M Green; Nicholas van de Velde; Julie L McAuley; Kelli L Boyd; Hazem E Ghoneim; Jonathan A McCullers
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60.

Authors:  Hong Jin; Helen Zhou; Bin Lu; George Kemble
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens.

Authors:  Diane J Hulse; Robert G Webster; Rupert J Russell; Daniel R Perez
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  DDX3 Interacts with Influenza A Virus NS1 and NP Proteins and Exerts Antiviral Function through Regulation of Stress Granule Formation.

Authors:  Sathya N Thulasi Raman; Guanqun Liu; Hyun Mi Pyo; Ya Cheng Cui; Fang Xu; Lisanework E Ayalew; Suresh K Tikoo; Yan Zhou
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

5.  Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines.

Authors:  Erich Hoffmann; Aleksandr S Lipatov; Richard J Webby; Elena A Govorkova; Robert G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

6.  Deletions in the neuraminidase stalk region of H2N2 and H9N2 avian influenza virus subtypes do not affect postinfluenza secondary bacterial pneumonia.

Authors:  Ashok K Chockalingam; Danielle Hickman; Lindomar Pena; Jianqiang Ye; Andrea Ferrero; Jose R Echenique; Hongjun Chen; Troy Sutton; Daniel R Perez
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

7.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

8.  Influenza virus neuraminidase contributes to secondary bacterial pneumonia.

Authors:  Ville T Peltola; K Gopal Murti; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2005-06-08       Impact factor: 5.226

9.  Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.

Authors:  Glendie Marcelin; Hilliary M Bland; Nicholas J Negovetich; Matthew R Sandbulte; Ali H Ellebedy; Ashley D Webb; Yolanda S Griffin; Jennifer L DeBeauchamp; Janet E McElhaney; Richard J Webby
Journal:  J Infect Dis       Date:  2010-10-27       Impact factor: 5.226

10.  PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.

Authors:  Anke R M Kraft; Myriam F Wlodarczyk; Laurie L Kenney; Liisa K Selin
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.